- AbbVie and Genmab pipeline updates and regulatory engagement
- AbbVie and Genmab will engage global regulatory authorities regarding their joint development efforts.
A collaboration between AbbVie, Genmab, and Nxera Pharma has seen joint trial success, leading to potential milestone payments and favorable opinions from the European Commission.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A collaboration between AbbVie, Genmab, and Nxera Pharma has seen joint trial success, leading to potential milestone payments and favorable opinions from the European Commission.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AbbVie
pharmaceutical company
Nothing else this week.
-
Genmab
Danish healthcare company
Nothing else this week.
-
Nxera Pharma
company in Tokyo, Japan
Nothing else this week.